Just In
- 1 hr ago Met Gala 2024: Date, Theme, Venue, Guest List, All You Need To Know About The Fashion Event
- 8 hrs ago Summer Fashion: Your Bollywood Style White Outfits Guide To Keep It Cool And Chic
- 9 hrs ago Sonam Kapoor Stuns In A Huisang Zhang Skirt Set, A Skirt-Top Style Guide From The OG Fashionista!
- 12 hrs ago Thrissur Pooram 2024: Date, Time, History, Significance, And Celebrations Related To Kerala's Rich Traditions
Don't Miss
- Sports LSG vs CSK: 'Mahi Maar Raha Hain' - Twitter goes Crazy as MS Dhoni shows Batting Magic at Ekana Stadium
- Movies When Karan Johar Revealed Sara Ali Khan And Janhvi Kapoor Once Dated Siblings On KWK 7, Guess Who?
- Finance Reliance, ONGC, Tata, Adanis: Energy Stocks Didn't Get The Memo Of Bears, Up 12% In 30-Days; 10 Stocks To BUY
- News Trust Of The Nation 2024: PM Modi Is Poised For A Resounding Victory, Shows Dailyhunt Survey
- Automobiles Suzuki Swift Hatchback Scores 4 Star Safety Rating At JNCAP – ADAS, New Engine & More
- Education NLSIU Announces the Rajiv K. Luthra Foundation Grant
- Technology Dell Introduces AI-Powered Laptops and Mobile Workstations for Enterprises in India
- Travel Journey From Delhi To Ooty: Top Transport Options And Attractions
NTAGI Recommends Vaccination Against Cervical Cancer And Typhoid: Sources
The government advisory panel NTAGI on Tuesday is learnt to have recommended vaccination against cervical cancer and typhoid after examining the data in this regard. The separately constituted HPV working group of NTAGI had on June 8 reviewed the clinical trial data and the usefulness of Serum Institute's indigenously-developed and India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer for inclusion in the National Immunization program, sources said.
According to official sources, the subject expert committee of Central Drugs Standard Control Organisation (CDSCO) had on June 15 recommended granting market authorisation to the qHPV jab. The approval of the Drugs Controller General of India (DCGI) in the matter is still awaited.
Prakash Kumar Singh, director, government and regulatory affairs at Serum Institute of India (SII) had applied to DCGI seeking market authorisation of qHPV after the phase 2/3 clinical trial was completed with the support of the Department of Biotechnology to ensure its early availability in the country, sources said.
According to the application submitted to DCGI by Singh, qHPV vaccine CERVAVAC has demonstrated robust antibody response that is nearly 1,000 times higher than the baseline against all targeted HPV types and in all dose and age groups.
The application mentioned that lakhs of women are diagnosed every year with cervical cancer as well as few other cancers and the death ratio is also very high.
Cervical cancer in India ranks as the second most frequent cancer among women between 15 and 44 years of age.
Also, it is noteworthy that presently India is fully dependent on foreign manufacturers for the HPV vaccine.
Typhoid is a bacterial infection that can lead to high fever, diarrhoea and vomiting. It is caused by the bacterium Salmonella typhimurium (S. typhi). If not detected and treated early, it can be fatal.
- health4 Diseases You Can Take Vaccine For Even After You Turn 40: Is It Too Late to Get Hepatitis B Vaccine?
- healthNobel Prize 2023: Scientists Behind The COVID-19 mRNA Vaccines Wins
- healthCOVID-19 Vaccines and Heart Attacks: New Studies Show Different Results; What Are They?
- healthCancer, Heart Disease Vaccine To Be Ready By 2030: Know More Here
- healthXBB.1.16: Symptoms; Are Vaccines Useful? WHO Concerned Over Recent COVID Spike In India
- wellnessNational Vaccination Day: List Of Vaccines Every Adult Over 50 Should Get
- disorders cureNational Vaccination Day 2023: Diseases For Which No Vaccines Are Currently Available
- disorders cureCervical Cancer: Serum Institute Of India Launches First HPV Vaccine For Cervical Cancer
- wellnessDissolving Vaccine Tablets For Urinary Tract Infections: Important Points
- wellnessCentury-Old TB Vaccine Could Be Effective Against Covid-19 And Other Infections: New Study
- healthNew York Reports First Ever Case Of Polio, Nearly After A Decade: What You Need To Know
- wellnessGap Between Second And Precaution Dose Of Covid-19 Vaccine Reduced To 6 Months